Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114920652B enables mild photocatalytic synthesis reducing costs and improving supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.
Patent CN120349297A reveals photocatalytic synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain solutions.
Patent CN119591507B reveals a novel photocatalytic route for gem-difluorocyclopentane. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity supply.
Patent CN110698393A discloses a metal-free radical relay method using fluorinated oxime ethers for efficient drug intermediate synthesis, offering significant cost reduction and supply chain reliability.
Novel asymmetric synthesis method for high-purity pharmaceutical intermediates ensuring supply chain reliability and cost reduction.
Patent CN101535290A reveals a protective-group-free hydrogenation method for 2-alkyl-3-aminothiophene derivatives, offering significant cost reduction and scalable manufacturing for agrochemical intermediates.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Novel one-step synthesis improves yield by 15-30%. Offers cost-effective scalable production for global supply chains.
Patent CN119684221B reveals metal-free photocatalysis for quinoxalinone derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel catalytic oxidation method improves yield to 38% for Pyroxasulfone, offering cost-effective agrochemical intermediate manufacturing solutions.
Advanced catalytic reduction route for Rivastigmine Tartrate offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN118048636A reveals mild cobalt-catalyzed electrochemical route. Offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN113461679B reveals a novel 5-step synthesis for benzazepine isatin intermediates, offering mild conditions and high purity for pharmaceutical applications.
Patent CN103554117B enables high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing with metal-free catalysis.
Patent CN114182272B reveals a metal-free electrochemical route for alcohol and pinacol derivatives, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN105820166A enables green photocatalytic synthesis of dihydrocarboline. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103319526B enables high stereoselective synthesis of phosphorus chiral centers. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN112410807A reveals a metal-free electrochemical route for sulfonated vinyl ethers, offering greener synthesis and cost reduction for pharmaceutical intermediates.
Novel photocatalytic route for anti-tumor indoline intermediates ensures high purity and scalable supply chain efficiency for global pharmaceutical manufacturing partners.